Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Recent advances in bioplastics: application and biodegradation
The success of oil-based plastics and the continued growth of production and utilisation can
be attributed to their cost, durability, strength to weight ratio, and eight contributions to the …
be attributed to their cost, durability, strength to weight ratio, and eight contributions to the …
2018 ESC/EACTS Guidelines on myocardial revascularization
These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …
2018 ESC/EACTS Guidelines on myocardial revascularization
always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …
websites. The National Societies of the ESC are encouraged to endorse, translate, and …
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 …
PW Serruys, B Chevalier, Y Sotomi, A Cequier… - The Lancet, 2016 - thelancet.com
Background No medium-term data are available on the random comparison between
everolimus-eluting bioresorbable vascular scaffolds and everolimus-eluting metallic stents …
everolimus-eluting bioresorbable vascular scaffolds and everolimus-eluting metallic stents …
Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014
Modern-day stenting procedures leverage advances in pharmacotherapy and device
innovation. Patients treated with contemporary antiplatelet agents, peri-procedural …
innovation. Patients treated with contemporary antiplatelet agents, peri-procedural …
Biodegradable metals for cardiovascular stents: from clinical concerns to recent Zn‐Alloys
Metallic stents are used to promote revascularization and maintain patency of plaqued or
damaged arteries following balloon angioplasty. To mitigate the long‐term side effects …
damaged arteries following balloon angioplasty. To mitigate the long‐term side effects …
Biopolymer-based functional composites for medical applications
Over the last decade, numerous biopolymers have received more attention in medical
applications involving novel biomaterials because of their biocompatibility, biodegradability …
applications involving novel biomaterials because of their biocompatibility, biodegradability …
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials
Background Bioresorbable coronary stents might improve outcomes of patients treated with
percutaneous coronary interventions. The everolimus-eluting bioresorbable vascular …
percutaneous coronary interventions. The everolimus-eluting bioresorbable vascular …
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month …
Background Absorbable scaffolds were designed to overcome the limitations of
conventional, non-absorbable metal-based drug-eluting stents. So far, only polymeric …
conventional, non-absorbable metal-based drug-eluting stents. So far, only polymeric …